Funder
National Natural Science Foundation of China
Reference53 articles.
1. Biologics and airway remodeling in severe asthma;Varricchi;Allergy,2022
2. Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial;Diver;The Lancet Respir. Med.,2021
3. Biologics for severe asthma-Which, when and why?;Shah;Respirology (Carlton, Vic.),2023
4. Exposome profiles and asthma among French adults;Guillien;Am. J. Respir. Crit. Care Med.,2022
5. Early life microbial exposures and allergy risks: opportunities for prevention;Renz;Nat. Rev. Immunol.,2021